The estimated Net Worth of Eldon C. Iii Mayer is at least $795 Thousand dollars as of 17 March 2023. Mr Mayer owns over 4,395 units of Eiger BioPharmaceuticals Inc stock worth over $96,726 and over the last 8 years he sold EIGR stock worth over $41,443. In addition, he makes $657,153 as Exec. VP & Chief Commercial Officer at Eiger BioPharmaceuticals Inc.
Mr has made over 9 trades of the Eiger BioPharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 4,395 units of EIGR stock worth $4,703 on 17 March 2023.
The largest trade he's ever made was buying 100,000 units of Eiger BioPharmaceuticals Inc stock on 10 September 2018 worth over $326,000. On average, Mr trades about 9,572 units every 67 days since 2016. As of 17 March 2023 he still owns at least 56,073 units of Eiger BioPharmaceuticals Inc stock.
You can see the complete history of Mr Mayer stock trades at the bottom of the page.
Eldon C. Mayer III, M.B.A. is the Exec. VP & Chief Commercial Officer at Eiger BioPharmaceuticals Inc.
As the Exec. VP & Chief Commercial Officer of Eiger BioPharmaceuticals Inc, the total compensation of Mr A at Eiger BioPharmaceuticals Inc is $657,153. There are 7 executives at Eiger BioPharmaceuticals Inc getting paid more, with David Cory having the highest compensation of $2,871,850.
Mr A is 60, he's been the Exec. VP & Chief Commercial Officer of Eiger BioPharmaceuticals Inc since . There are 3 older and 15 younger executives at Eiger BioPharmaceuticals Inc. The oldest executive at Eiger BioPharmaceuticals Inc is Dr. Colin Hislop, 63, who is the Sr. VP of Clinical & Devel. Operations.
Eldon's mailing address filed with the SEC is C/O EIGER BIOPHARMACEUTICALS, INC., 2155 PARK BLVD., PALO ALTO, CA, 94306.
Over the last 9 years, insiders at Eiger BioPharmaceuticals Inc have traded over $3,017,304 worth of Eiger BioPharmaceuticals Inc stock and bought 780,533 units worth $4,706,203 . The most active insiders traders include Richard A Kayne, Edgar Engleman, and Partners X Lp Inter West Ma.... On average, Eiger BioPharmaceuticals Inc executives and independent directors trade stock every 70 days with the average trade being worth of $47,232. The most recent stock trade was executed by Richard A Kayne on 31 October 2023, trading 278,239 units of EIGR stock currently worth $72,342.
eiger inc is a research company located in 500 crescent ct ste 300, dallas, texas, united states.
Eiger BioPharmaceuticals Inc executives and other stock owners filed with the SEC include: